Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Cellegy submits NDS for Rectogesic approval in Canada

March 27, 2002

Licensing opportunity from NIH: use of CpG oligodeoxynucleotides to promote angiogenesis

March 26, 2002

Novel antibiotic for acne enters phase I testing

March 26, 2002

Daclizumab fails to meet endpoint as maintenance treatment in psoriasis

March 22, 2002

Investigators at Shiseido identify new MMP inhibitors

March 21, 2002

Centocor patents series of anti-IL-12 antibodies

March 21, 2002

First European country approves Elidel for atopic dermatitis

March 19, 2002

Optimal treatment regimen for Vasogen's immune modulation therapy identified

March 18, 2002

Protopic cleared for launch in Europe

March 15, 2002

New nonsteroidal therapy for atopic eczema effective in over two-thirds of adults

March 14, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...